User:Abeer M. Al-Ghananeem: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
Line 25: | Line 25: | ||
<!-- Replace the PubMed ID's ("pmid=#######") below with the PubMed ID's for your publications. You can add or remove lines as needed --> | <!-- Replace the PubMed ID's ("pmid=#######") below with the PubMed ID's for your publications. You can add or remove lines as needed --> | ||
<biblio> | <biblio> | ||
#Paper1 pmid= | #Paper1 pmid=21244195 | ||
#Paper2 pmid= | #Paper2 pmid=19929567 | ||
// leave a comment about a paper here | // leave a comment about a paper here | ||
#Book1 isbn=0879697164 | #Book1 isbn=0879697164 |
Revision as of 11:14, 3 April 2013
I am a new member of OpenWetWare!
Contact Info
- Abeer M. Al-Ghananeem
- Professor and Associate Dean of Research and Graduate Program, Sullivan University College of Pharmacy
- 2100 Gardiner Lane, Louisville KY, 40205.
- Email me through OpenWetWare
Education
- 1999, PhD, University of Kentucky
- 1999, MS, University of Kentucky
- 1993, B.Sc, Jordan University
Research interests
- Drug Development
- Targeted Delivery
- Clinical Pharmacokinetics
- Pharmaceutical Technology.
Publications
- Al-Ghananeem AM, Malkawi AH, and Crooks PA. Bioavailability of Δ⁹-tetrahydrocannabinol following intranasal administration of a mucoadhesive gel spray delivery system in conscious rabbits. Drug Dev Ind Pharm. 2011 Mar;37(3):329-34. DOI:10.3109/03639045.2010.513009 |
- Al-Ghananeem AM, Abbassi M, Shrestha S, Raman G, Wulff H, Pereira L, and Ansari A. Formulation-based approach to support early drug discovery and development efforts: a case study with enteric microencapsulation dosage form development for a triarylmethane derivative TRAM-34; a novel potential immunosuppressant. Drug Dev Ind Pharm. 2010 May;36(5):563-9. DOI:10.3109/03639040903329554 |
leave a comment about a paper here
- ISBN:0879697164